According to the authors, brain insulin resistance appears to be an early and common feature of AD, a phenomenon accompanied by IGF-1 resistance and closely associated with the insulin receptor substrate 1 (IRS-1) dysfunction, which is a critical element in the insulin-signaling pathway, potentially triggered by Aβ oligomers and cognitive decline. The gene discussed is IGF1; the disease is Insulin resistance.